ROIV

#579
Roivant Sciences Ltd. Common Shares
29.1200 USD
+0.59%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
29.1200
29.1200
年范围
18.2700
30.3300
日变化
+0.59%
每月变动
+2.19%
6个月变化
+59.04%
年变化
+59.04%
前一天收盘价
28.9500
开盘价
29.1200
买价
卖价
最低价
29.1200
High
29.1200
交易量
171
展开完整图表

Financials

概览 声明 统计
每季度 年度
  • Market Capitalization 20.8412 B
  • Employee 750
  • Founded 2014
  • CEO Matt Gline
  • Website www.roivant.com
  • Headquarter Bermuda
  • FIGI N/A
  • Industry Technology
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
-42.04
市销率
251.93

Roivant Sciences Ltd

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.

新闻